Publications Plus
Text Size

Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl

Iwamura R., Tanaka M., Okanari E., Kirihara T., Odani-Kawabata N., Shams N., Yoneda K.

  • 2018
  • Journal of Medicinal Chemistry
View publication

  • Therapeutic Area

    Glaucoma

  • Technology

    Other

  • Categories

    Preclinical development

  • Affiliations

    Pharmaceuticals Research Laboratory, UBE Industries, Ltd., 1978-5 Kogushi, Ube Yamaguchi, 755-8633, Japan; R and D Division, Santen Pharmaceutical Co., Ltd., Grand Front Osaka Tower A 4-20, Ofukacho, Kita-ku. Osaka, 530-8552, Japan; R and D Division, Santen Inc., 6401 Hollis Street, Emeryville, CA 94608, United States

Related Publications

Long-term safety and efficacy of sepetaprost, with or without timolol, in patients with open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J2 study

Inatani M., Tone Y., Ikeda T., Angeles R.

  • 2026
  • Jpn J Ophthalmol
View publication

Efficacy and safety of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J1 study

Inatani M., Kanamori A., Inai M., Ikeda T., Angeles R.

  • 2026
  • Jpn J Ophthalmol
View publication

Clinical outcomes of Preserflo MicroShunt implant procedure in open‑angle glaucoma patients – a 1000 eyes case-series; including subanalysis of combined cataract-glaucoma surgery and standalone surgery in pseudophakic eyes

Klabe, K.; Werth, J.P.; Kaymak, H. ; Fricke, A.

  • 2026
  • Graefe's Archive for Clinical and Experimental Ophthalmology
View publication
View all Glaucoma publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022

Our use of cookies

We use cookies that are strictly necessary to operate this website. We also use optional cookies to improve your accessibility to our website and its functionality, to analyse and track your use of our website and to give you the best possible user experience. You will need to activate optional cookies. For more detailed information on our use of cookies on this website, please read our Cookie Policy, which also explains how to customise your Cookies settings. You can also accept all our cookies or customise your Cookies settings by clicking on the buttons provided below.

Cookie Settings